文献速递神经肿瘤

经口机器人手术治疗鞍区肿瘤:首次临床研究

Transoral robotic surgery for sellar tumors: first clinical study.
PubMed 文献 · J Neurosurg · 2016-12-23

这项前瞻性研究纳入4例有症状的鞍区肿瘤患者,采用da Vinci手术系统行经口机器人手术(TORS),无需切开软腭。所有病例鞍区可达性满意,3例肿瘤完全切除,平均手术时间2小时43分钟;术后1例迟发性脑脊液漏、1例短暂性尿崩症,3例术后第1天视力明显改善。作者认为该术式可行,可能避免经典经鼻蝶入路的不良反应和技术缺点。

要点

  • 4例有症状鞍区肿瘤患者均经TORS完成手术,无需二次手术,鞍区可达性均满意。
  • 3例肿瘤完全切除,平均手术时间2小时43分钟,3例术后第1天视力明显改善。
  • 术后1例迟发性脑脊液漏、1例短暂性尿崩症;TORS特有不良反应包括轻微咽痛、短暂性鼻音过重及1例迟发性中耳炎。

核心结论

  • 作者认为这是首例采用微创TORS治疗鞍区肿瘤的报告,使用da Vinci手术系统似乎可行,是一种可能避免经典经蝶入路不良反应和技术缺点的创新神经外科技术。
  • TORS可提供自下而上的鞍区入路,使肿瘤沿其生长方向被接近,作者认为这是关键点。

研究设计与样本

  • 前瞻性研究,纳入有症状的鞍区肿瘤患者,入组需满足基于术前张口位头颅CT确定的特定解剖特征。
  • 2016年2月至5月共4例患者(均为女性,平均年龄49.5岁)接受TORS切除鞍区肿瘤。
  • 主要结局指标为机器人鞍区可达性,另报告切除质量、平均手术时间、术后视力变化、不良反应和并发症。

主要发现

  • 4例患者均表现为有症状的视力缺损,确诊为双颞侧偏盲;所有肿瘤均有鞍上部分和囊性部分。
  • 4例均经TORS完成手术,无需二次手术;鞍区可达性均满意,3例肿瘤完全切除。
  • 平均手术时间为2小时43分钟;3例患者术后第1天视力明显改善。
  • 术后出现1例迟发性脑脊液漏和1例短暂性尿崩症;TORS特有不良反应包括轻微咽痛、短暂性鼻音过重和1例迟发性中耳炎。
  • 平均住院时间和平均随访时间分别为8.25天和82天;未对肿瘤液体成分进行病理检查。

局限性

  • 未对肿瘤液体成分进行病理检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE The aim of this study was to confirm the feasibility of an innovative transoral robotic surgery (TORS), using the da Vinci Surgical System, for patients with sellar tumors. This technique was designed to offer a new minimally invasive approach, without soft-palate splitting, that avoids the rhinological side effects of classic endonasal approaches. METHODS The authors performed a prospective study of TORS in patients with symptomatic sellar tumors. Specific anatomical features were required for inclusion in the study and were determined on the basis of preoperative open-mouth CT scans of the brain. The main outcome measure was sellar accessibility using the robot. Resection quality, mean operative time, postoperative changes in patients' vision, side effects, and complications were additionally reported. RESULTS Between February and May 2016, 4 patients (all female, mean age 49.5 years) underwent TORS for resection of sellar tumors as participants in this study. All patients presented with symptomatic visual deficits confirmed as bitemporal hemianopsia. All tumors had a suprasellar portion and a cystic part. In all 4 cases, the operation was performed via TORS, without the need for a second surgery. Sella turcica accessibility was satisfactory in all cases. In 3 cases, tumor resection was complete. The mean operative time was 2 hours 43 minutes. Three patients had a significant visual improvement at Day 1. No rhinological side effects or complications in patients occurred. No pathological examination was performed regarding the fluid component of the tumors. There was 1 postoperative delayed CSF leak and 1 case of transient diabetes insipidus. Side effects specific to TORS included minor sore throat, transient hypernasal speech, and 1 case of delayed otitis media. The mean length of hospital stay and mean follow up were 8.25 days and 82 days, respectively. CONCLUSIONS To our knowledge, this is the first report of the surgical treatment of sellar tumors by means of a minimally invasive TORS. This approach using the da Vinci Surgical System seems feasible and constitutes an innovative neurosurgical technique that may avoid the adverse side effects and technical disadvantages of the classic transsphenoidal route. Moreover, TORS allows an inferosuperior approach to the sella turcica, which is a key point, as the tumor is approached in the direction of its growth.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Chauvet D, Hans S, Missistrano A, et al. Transoral robotic surgery for sellar tumors: first clinical study. J Neurosurg. 2016. PMID: 28009229. doi:10.3171/2016.9.JNS161638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。